Artificial Intelligence

A new national standard removes the mandatory mechanical steering link, paving the way for radical vehicle designs and cementing China's lead in auto tech.

AI drug discovery firm Insilico Medicine soars in its Hong Kong debut, the city's largest biotech IPO of 2025, validating a new tech-driven era for medicine.

As AI tools multiply, Cloudhands emerges with a unified platform and veteran leadership, promising to end the chaos of juggling multiple models.

DAREU is set to unveil three high-performance peripherals at CES 2026, combining advanced magnetic switches with an aggressive global expansion strategy.

Dr. Lu Xianping, crowned EY Entrepreneur Of The Year, didn't just invent new drugs; he helped reinvent China's entire pharmaceutical industry.

At CES 2026, Seyond debuts its Hummingbird solid-state LiDAR with a major OEM win, challenging rivals in a race to define the future of autonomy.

FeatherSnap heads to CES 2026 with its AI bird feeders, highlighting the smart home's expansion into nature, citizen science, and a competitive market.

Vivakor blames a government shutdown for its dividend delay, but shareholders are left grappling with an unusual asset and a complex CEO-related deal.

All eyes are on Sandisk's Jan 29 report. Can the reborn flash memory leader meet lofty expectations and prove its post-spin-off strategy is a success?

Cannabix Technologies lands its first international order for its smart breathalyzer in Australia, a move that validates its tech and reshapes its finances.

With strong financials and new clinical data, medical device leader Penumbra is set to detail its growth strategy at healthcare's top investor event.

After a year of major acquisitions and AI-driven innovation, all eyes are on Labcorp's strategic vision for 2026 at the J.P. Morgan Healthcare Conference.

As 10x Genomics preps for its J.P. Morgan spotlight, investors seek a clear path to profit amid fierce competition and groundbreaking innovation.

Sidus Space nets nearly $15M in a new offering to scale satellite production and defense tech, sparking investor optimism despite financial pressures.

Amidst legal industry fears of generative AI, BriefCatch's $6M funding and stellar retention prove the value of a trusted, specialized AI writing partner.

With CEO David Endicott set to present at the J.P. Morgan Healthcare Conference, all eyes are on Alcon's strategy for innovation and market growth.

Amid market volatility and a green energy push, Devon's CEO will outline the firm's strategy for navigating a complex 2026 at a top industry event.

PacBio heads to J.P. Morgan's conference with new tech aimed at making long-read sequencing cheaper. Can it challenge rivals and win over investors?

SOLAI shareholders approved a massive 30 billion share increase, arming the firm for a radical pivot into AI and the Solana ecosystem. But what about dilution?

Profound Medical raises over $42M to advance its AI-powered, incision-free therapies for cancer and other diseases, signaling strong investor confidence.